These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 10696111)

  • 1. Macroporous polymer foams by hydrocarbon templating.
    Shastri VP; Martin I; Langer R
    Proc Natl Acad Sci U S A; 2000 Feb; 97(5):1970-5. PubMed ID: 10696111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable polymeric microcellular foams by modified thermally induced phase separation method.
    Nam YS; Park TG
    Biomaterials; 1999 Oct; 20(19):1783-90. PubMed ID: 10509188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(alpha-hydroxyl acids)/hydroxyapatite porous composites for bone-tissue engineering. I. Preparation and morphology.
    Zhang R; Ma PX
    J Biomed Mater Res; 1999 Mar; 44(4):446-55. PubMed ID: 10397949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel approach to fabricate porous sponges of poly(D,L-lactic-co-glycolic acid) without the use of organic solvents.
    Mooney DJ; Baldwin DF; Suh NP; Vacanti JP; Langer R
    Biomaterials; 1996 Jul; 17(14):1417-22. PubMed ID: 8830969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyapatite fiber reinforced poly(alpha-hydroxy ester) foams for bone regeneration.
    Thomson RC; Yaszemski MJ; Powers JM; Mikos AG
    Biomaterials; 1998 Nov; 19(21):1935-43. PubMed ID: 9863527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of poly(L-lactic acid) and poly(DL-lactic-co-glycolic acid) foams by use of ice microparticulates.
    Chen G; Ushida T; Tateishi T
    Biomaterials; 2001 Sep; 22(18):2563-7. PubMed ID: 11516089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams.
    Lu L; Peter SJ; Lyman MD; Lai HL; Leite SM; Tamada JA; Uyama S; Vacanti JP; Langer R; Mikos AG
    Biomaterials; 2000 Sep; 21(18):1837-45. PubMed ID: 10919687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of cylinder-shaped porous sponges of poly(L-lactic acid), poly(DL-lactic-co-glycolic acid), and poly(ε-caprolactone).
    He X; Kawazoe N; Chen G
    Biomed Res Int; 2014; 2014():106082. PubMed ID: 24719843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of porous microcellular 85/15 poly (DL-lactide-co-glycolide) foams for biomedical applications.
    Singh L; Kumar V; Ratner BD
    Biomaterials; 2004 Jun; 25(13):2611-7. PubMed ID: 14751747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fabrication of poly(alpha-hydroxy acid) foam scaffolds using multiple solvent systems.
    Hu Y; Grainger DW; Winn SR; Hollinger JO
    J Biomed Mater Res; 2002 Mar; 59(3):563-72. PubMed ID: 11774315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wetting of poly(L-lactic acid) and poly(DL-lactic-co-glycolic acid) foams for tissue culture.
    Mikos AG; Lyman MD; Freed LE; Langer R
    Biomaterials; 1994 Jan; 15(1):55-8. PubMed ID: 8161659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porous poly(alpha-hydroxyacid)/Bioglass composite scaffolds for bone tissue engineering. I: Preparation and in vitro characterisation.
    Maquet V; Boccaccini AR; Pravata L; Notingher I; Jérôme R
    Biomaterials; 2004 Aug; 25(18):4185-94. PubMed ID: 15046908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of some factors on fabrication of poly(L-lactic acid) microporous foams by thermally induced phase separation using N,N-dimethylacetamide as solvent.
    Li S; Chen X; Li M
    Prep Biochem Biotechnol; 2011; 41(1):53-72. PubMed ID: 21229464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porous biodegradable polymeric scaffolds prepared by thermally induced phase separation.
    Nam YS; Park TG
    J Biomed Mater Res; 1999 Oct; 47(1):8-17. PubMed ID: 10400875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why degradable polymers undergo surface erosion or bulk erosion.
    von Burkersroda F; Schedl L; Göpferich A
    Biomaterials; 2002 Nov; 23(21):4221-31. PubMed ID: 12194525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro degradation of porous poly(L-lactic acid) foams.
    Lu L; Peter SJ; Lyman MD; Lai HL; Leite SM; Tamada JA; Vacanti JP; Langer R; Mikos AG
    Biomaterials; 2000 Aug; 21(15):1595-605. PubMed ID: 10885732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of polymer foam morphology and density on kinetics of in vitro controlled release of isoniazid from compressed foam matrices.
    Hsu YY; Gresser JD; Trantolo DJ; Lyons CM; Gangadharam PR; Wise DL
    J Biomed Mater Res; 1997 Apr; 35(1):107-16. PubMed ID: 9104703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic nano-scale fibrous extracellular matrix.
    Ma PX; Zhang R
    J Biomed Mater Res; 1999 Jul; 46(1):60-72. PubMed ID: 10357136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structured Biodegradable Polymeric Microparticles for Drug Delivery Produced Using Flow Focusing Glass Microfluidic Devices.
    Ekanem EE; Nabavi SA; Vladisavljević GT; Gu S
    ACS Appl Mater Interfaces; 2015 Oct; 7(41):23132-43. PubMed ID: 26423218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds.
    Ishaug SL; Crane GM; Miller MJ; Yasko AW; Yaszemski MJ; Mikos AG
    J Biomed Mater Res; 1997 Jul; 36(1):17-28. PubMed ID: 9212385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.